| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.403 | 13.032 | 11.446 | 4.141 | 4.399 | 2.763 | 1.739 | 2.222 | 3.129 | 3.165 |
| Total Income - EUR | 18.425 | 13.032 | 11.446 | 4.141 | 4.399 | 2.763 | 1.739 | 2.222 | 3.129 | 3.165 |
| Total Expenses - EUR | 21.656 | 15.327 | 13.290 | 16.819 | 5.993 | 3.408 | 1.504 | 1.505 | 8.852 | 5.880 |
| Gross Profit/Loss - EUR | -3.231 | -2.295 | -1.843 | -12.678 | -1.594 | -645 | 235 | 717 | -5.723 | -2.715 |
| Net Profit/Loss - EUR | -3.784 | -2.639 | -2.187 | -12.803 | -1.726 | -728 | 183 | 650 | -5.723 | -2.715 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Jeni Pharma 2008 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | -19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 13.192 | 13.546 | 13.743 | 6.849 | 10.818 | 12.763 | 4.659 | 6.108 | 2.394 | 3.173 |
| Inventories | 12.924 | 13.272 | 13.077 | 6.396 | 10.021 | 11.577 | 3.439 | 4.821 | 764 | 2.452 |
| Receivables | 2 | 2 | 2 | 331 | 519 | 742 | 953 | 991 | 959 | 913 |
| Cash | 266 | 272 | 664 | 122 | 277 | 445 | 267 | 296 | 671 | -191 |
| Shareholders Funds | -20.345 | -22.777 | -24.578 | -36.930 | -37.940 | -37.949 | -47.032 | -46.528 | -52.110 | -54.534 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.518 | 36.323 | 38.321 | 43.779 | 48.758 | 50.713 | 51.692 | 52.636 | 54.504 | 57.707 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Jeni Pharma 2008 S.r.l.